ICU Medical (NASDAQ:ICUI) Hits New 52-Week Low at $154.37

ICU Medical, Inc. (NASDAQ:ICUIGet Rating) shares hit a new 52-week low on Monday . The stock traded as low as $154.37 and last traded at $154.75, with a volume of 1619 shares trading hands. The stock had previously closed at $161.72.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ICUI. StockNews.com upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a research note on Monday, September 5th. KeyCorp lowered their target price on shares of ICU Medical from $230.00 to $225.00 in a research note on Tuesday, August 9th. Finally, Raymond James lowered their target price on shares of ICU Medical from $208.00 to $190.00 and set an “outperform” rating for the company in a research note on Tuesday, August 9th.

ICU Medical Stock Down 3.0 %

The company’s 50 day moving average price is $168.71 and its 200 day moving average price is $187.99. The company has a quick ratio of 1.25, a current ratio of 2.45 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $3.73 billion, a price-to-earnings ratio of 371.44 and a beta of 0.57.

ICU Medical (NASDAQ:ICUIGet Rating) last posted its quarterly earnings data on Monday, August 8th. The medical instruments supplier reported $1.37 EPS for the quarter, missing the consensus estimate of $1.68 by ($0.31). ICU Medical had a return on equity of 6.97% and a net margin of 0.31%. The company had revenue of $561.00 million for the quarter, compared to analyst estimates of $569.30 million. During the same quarter in the previous year, the firm posted $1.57 earnings per share. The company’s quarterly revenue was up 74.4% on a year-over-year basis. As a group, research analysts forecast that ICU Medical, Inc. will post 5.23 earnings per share for the current fiscal year.

Institutional Investors Weigh In On ICU Medical

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in shares of ICU Medical by 8.8% during the first quarter. Vanguard Group Inc. now owns 2,122,104 shares of the medical instruments supplier’s stock worth $472,466,000 after buying an additional 171,851 shares during the period. Wellington Management Group LLP raised its holdings in shares of ICU Medical by 71.6% during the first quarter. Wellington Management Group LLP now owns 1,516,089 shares of the medical instruments supplier’s stock worth $337,542,000 after purchasing an additional 632,609 shares during the last quarter. Nuance Investments LLC raised its holdings in shares of ICU Medical by 93.1% during the second quarter. Nuance Investments LLC now owns 1,008,937 shares of the medical instruments supplier’s stock worth $165,859,000 after purchasing an additional 486,551 shares during the last quarter. State Street Corp raised its holdings in shares of ICU Medical by 2.0% during the fourth quarter. State Street Corp now owns 559,026 shares of the medical instruments supplier’s stock worth $132,679,000 after purchasing an additional 11,038 shares during the last quarter. Finally, Point72 Asset Management L.P. raised its holdings in shares of ICU Medical by 662.9% during the fourth quarter. Point72 Asset Management L.P. now owns 460,921 shares of the medical instruments supplier’s stock worth $109,395,000 after purchasing an additional 400,501 shares during the last quarter. 90.20% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

(Get Rating)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

See Also

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.